Reiss P - Search Results

1

Sources of HIV infection among men having sex with men and implications for prevention.

Ratmann O, van Sighem A, Bezemer D, Gavryushkina A, Jurriaans S, Wensing A, de Wolf F, Reiss P, Fraser C; ATHENA observational cohort. Ratmann O, et al. Among authors: reiss p. Sci Transl Med. 2016 Jan 6;8(320):320ra2. doi: 10.1126/scitranslmed.aad1863. Sci Transl Med. 2016. PMID: 26738795 Free PMC article.

2

Mortality and progression to AIDS after starting highly active antiretroviral therapy.

van Sighem AI, van de Wiel MA, Ghani AC, Jambroes M, Reiss P, Gyssens IC, Brinkman K, Lange JM, de Wolf F; ATHENA Cohort Study Group. van Sighem AI, et al. Among authors: reiss p. AIDS. 2003 Oct 17;17(15):2227-36. doi: 10.1097/00002030-200310170-00011. AIDS. 2003. PMID: 14523280

3

Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptase.

van der Hoek L, Back N, Jebbink MF, de Ronde A, Bakker M, Jurriaans S, Reiss P, Parkin N, Berkhout B. van der Hoek L, et al. Among authors: reiss p. J Virol. 2005 Mar;79(6):3536-43. doi: 10.1128/JVI.79.6.3536-3543.2005. J Virol. 2005. PMID: 15731248 Free PMC article.

4

Triple HIV-1 infection.

van der Kuyl AC, Kozaczynska K, van den Burg R, Zorgdrager F, Back N, Jurriaans S, Berkhout B, Reiss P, Cornelissen M. van der Kuyl AC, et al. Among authors: reiss p. N Engl J Med. 2005 Jun 16;352(24):2557-9. doi: 10.1056/NEJM200506163522420. N Engl J Med. 2005. PMID: 15958817 No abstract available.

5

CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater.

Gras L, Kesselring AM, Griffin JT, van Sighem AI, Fraser C, Ghani AC, Miedema F, Reiss P, Lange JM, de Wolf F; ATHENA, Netherlands National Observational Cohort Study. Gras L, et al. Among authors: reiss p. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):183-92. doi: 10.1097/QAI.0b013e31804d685b. J Acquir Immune Defic Syndr. 2007. PMID: 17414934

6

Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study.

Wit FW, Kesselring AM, Gras L, Richter C, van der Ende ME, Brinkman K, Lange JM, de Wolf F, Reiss P. Wit FW, et al. Among authors: reiss p. Clin Infect Dis. 2008 Mar 15;46(6):933-40. doi: 10.1086/528861. Clin Infect Dis. 2008. PMID: 18271750 Clinical Trial.

7

Immunologic, virologic, and clinical consequences of episodes of transient viremia during suppressive combination antiretroviral therapy.

van Sighem A, Zhang S, Reiss P, Gras L, van der Ende M, Kroon F, Prins J, de Wolf F. van Sighem A, et al. Among authors: reiss p. J Acquir Immune Defic Syndr. 2008 May 1;48(1):104-8. doi: 10.1097/QAI.0b013e31816a1d4f. J Acquir Immune Defic Syndr. 2008. PMID: 18285709

8

Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.

Antiretroviral Therapy Cohort Collaboration (ART-CC); Mocroft A, Sterne JA, Egger M, May M, Grabar S, Furrer H, Sabin C, Fatkenheuer G, Justice A, Reiss P, d'Arminio Monforte A, Gill J, Hogg R, Bonnet F, Kitahata M, Staszewski S, Casabona J, Harris R, Saag M. Antiretroviral Therapy Cohort Collaboration (ART-CC), et al. Among authors: reiss p. Clin Infect Dis. 2009 Apr 15;48(8):1138-51. doi: 10.1086/597468. Clin Infect Dis. 2009. PMID: 19275498 Free PMC article.

9

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.

Kesselring AM, Wit FW, Sabin CA, Lundgren JD, Gill MJ, Gatell JM, Rauch A, Montaner JS, de Wolf F, Reiss P, Mocroft A; Nevirapine Toxicity Multicohort Collaboration. Kesselring AM, et al. Among authors: reiss p. AIDS. 2009 Aug 24;23(13):1689-99. doi: 10.1097/QAD.0b013e32832d3b54. AIDS. 2009. PMID: 19487907

10

Safety and efficacy of once-daily nevirapine dosing: a multicohort study.

Calmy A, Vallier N, Nguyen A, Lange JM, Battegay M, de Wolf F, Reiss P, Lima VD, Hirschel B, Hogg RS, Yip B, Montaner JS, Wit FW; Swiss HIV Cohort study; HAART Observational Medical Evaluation and Research Cohort; Netherlands ATHENA Observational Cohort. Calmy A, et al. Among authors: reiss p. Antivir Ther. 2009;14(7):931-8. doi: 10.3851/IMP1418. Antivir Ther. 2009. PMID: 19918097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

883 results

Search Page